In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium

Background: The objective of this study wasto present initial systemic treatment choices and the outcome of hormone receptor-positive(HR+) metastaticbreastcancer. Patients and methods: All the 815 consecutive patients diagnosed with metastatic breast cancer in 2007–2009 in eight participating hospitals were identified. From the 611 patients with HR+ disease, a total of 520 patients with HER2-negative(HER2−)breastcancerwereincluded.Initial palliativesystemictreatment wasregistered. Progression-free survival (PFS) and overall survival (OS) per initial palliative systemic therapy were obtained usi... Mehr ...

Volltext
Verfasser: Lobbezoo, D.J.A.
van Kampen, R.J.W.
Voogd, A. C.
Dercksen, M. W.
van den Berkmortel, F.
Smilde, T. J.
van de Wouw, A. J.
Peters, F. P. J.
van Riel, J. M. G. H.
Peters, N. A. J. B.
de Boer, M.
Peer, P. G. M.
Tjan-Heijnen, V. C. G.
Dokumenttyp: Artikel
Erscheinungsdatum: 2016
Reihe/Periodikum: Lobbezoo , D J A , van Kampen , R J W , Voogd , A C , Dercksen , M W , van den Berkmortel , F , Smilde , T J , van de Wouw , A J , Peters , F P J , van Riel , J M G H , Peters , N A J B , de Boer , M , Peer , P G M & Tjan-Heijnen , V C G 2016 , ' In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium ' , Annals of Oncology , vol. 27 , no. 2 , pp. 256-262 . https://doi.org/10.1093/annonc/mdv544
Schlagwörter: metastatic breast cancer / chemotherapy / endocrine therapy / outcome / hormone receptor
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27206997
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://cris.maastrichtuniversity.nl/en/publications/e83f30bf-ab10-4e65-92e3-7e52e1349656